Edwards Lifesciences (EW) Interest & Investment Income (2010 - 2026)
Edwards Lifesciences' quarterly Interest & Investment Income came in at $33.5 million in Q1 2026, down 8.22% year-on-year from $36.5 million in Q1 2025, and down 40.5% quarter-over-quarter from $56.3 million in Q4 2025.
Edwards Lifesciences has reported Interest & Investment Income for 10 years, with the latest figure at $33.5 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 8.22% year-over-year to $33.5 million; the trailing twelve-month figure through Mar 2026 stood at $165.8 million (up 18.18% YoY), and the FY2025 full-year result was $168.8 million, up 40.32% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $33.5 million, down from $56.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $64.0 million in Q4 2024, with the low at $15.5 million in Q2 2024.
- Average Interest & Investment Income over 3 years is $35.8 million, with a median of $36.5 million recorded in 2025.
- Peak annual rise in Interest & Investment Income reached 141.29% in 2025, while the deepest fall reached 12.03% in 2025.
- Tracing EW's Interest & Investment Income over 3 years: stood at $64.0 million in 2024, then dropped by 12.03% to $56.3 million in 2025, then plunged by 40.5% to $33.5 million in 2026.
- The last three Interest & Investment Income figures came in at $33.5 million (Q1 2026), $56.3 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.50 Mn |
| Dec 31, 2025 | 56.30 Mn |
| Sep 30, 2025 | 38.60 Mn |
| Jun 30, 2025 | 37.40 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Dec 31, 2024 | 64.00 Mn |
| Sep 30, 2024 | 24.30 Mn |
| Jun 30, 2024 | 15.50 Mn |
| Mar 31, 2024 | 16.50 Mn |
| Dec 31, 2016 | 17.70 Mn |
| Sep 30, 2016 | -2.10 Mn |
| Jun 30, 2016 | -2.40 Mn |
| Mar 31, 2016 | -2.40 Mn |
| Dec 31, 2015 | 14.60 Mn |
| Sep 30, 2015 | -2.50 Mn |
| Jun 30, 2015 | -1.80 Mn |
| Mar 31, 2015 | -2.40 Mn |
| Dec 31, 2014 | 15.50 Mn |
| Sep 30, 2014 | -2.50 Mn |
| Jun 30, 2014 | -3.10 Mn |
| Mar 31, 2014 | -3.50 Mn |
| Dec 31, 2013 | 5.80 Mn |
| Sep 30, 2013 | -1.00 Mn |
| Jun 30, 2013 | -400,000.00 |
| Mar 31, 2013 | 200,000.00 |
| Dec 31, 2012 | 4.40 Mn |
| Sep 30, 2012 | 300,000.00 |
| Jun 30, 2012 | 100,000.00 |
| Dec 31, 2011 | 3.10 Mn |
| Jun 30, 2011 | 300,000.00 |
| Dec 31, 2010 | 2.00 Mn |
| Sep 30, 2010 | -400,000.00 |
| Jun 30, 2010 | -500,000.00 |